Simplified Approach to ACL Reconstruction Unveiled

Medacta Group SA has introduced a simplified approach for ACL correction.

The company’s M-ARS (Medacta – Anatomic Ribbon Surgery) anterior cruciate ligament (ACL) technique offers a more natural approach to ACL reconstruction than traditional round-graft-tunnel single-bundle solutions. It is designed to optimize knee biomechanics and enhance graft healing following ACL reconstruction, mimicking the native footprint by using a flat graft to enhance stress distribution and biological healing at the insertion site, potentially improving recovery time and patients’ return to an active lifestyle.
 
“Medacta’s new simplified approach for M-ARS ACL offers multiple advantages: it streamlines the creation of flat graft tunnels, making the surgical procedure more efficient and easier to perform, and it preserves the M-ARS philosophy of natural ACL reconstruction,” explained Prof. Dr. Fink, Austria.
 
“I prefer the simplified approach for the M-ARS ACL reconstruction system in combination with the MectaQTH minimally invasive quad-tendon harvesting system,” added Prof. Dr. Herbort, Germany. “This provides me with a wide range of devices to perform personalized primary and revision ACL reconstruction, as well as multi-ligament reconstruction.” 
 
Medacta’s Sports Medicine knee platform offers surgeons a range of surgical approaches to improve personalized medicine for primary, revision, and multi-ligament reconstruction. The platform includes devices, techniques, and education programs to support surgeons in achieving optimal patient outcomes.
 
Medacta’s M.O.R.E. Medical education program provides surgeons easy access to globally renowned reference centers and wet lab training. This program helps to accelerate the transition to arthroscopic natural anatomy knee reconstruction with the Sports Medicine knee platform.
 
Medacta designs, produces, and distributes personalized, sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving patient care and maintaining a focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized patient solutions. Through the M.O.R.E. Institute, Medacta supports surgeons with a program dedicated to advancing medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in more than 60 countries.